Transaction DateRecipientSharesTypePriceValue
6th November 2020Steve Aselage20,625Open or private sale$23.00$474,375.00
5th November 2020Steve Aselage2,500Open or private sale$21.26$53,150.00
12th October 2020William T. Andrews37,500Disposition due to a tender of shares in a change of control transaction$18.15$680,625.00
31st August 2020Steve Aselage2,409Grant/award etc.$4.15$9,997.35
5th August 2020Steve Aselage2,500Open or private sale$19.68$49,200.00
24th July 2020Steve Aselage45,000Open or private purchase$3.50$157,500.00
24th July 2020Chris Schelling142,857Open or private purchase$3.50$499,999.50
24th July 2020John Michael Dunn21,428Open or private purchase$3.50$74,998.00
24th July 2020Donald Joseph14,285Open or private purchase$3.50$49,997.50
9th July 2020William T. Andrews37,500Grant/award etc.$0.00
Opexa Therapeutics
Opexa Therapeutics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.



Ticker: OPXA
Sector: Unknown
Industry: Unknown
SEC Central Index Key (CIK): 1069308
Employees:
Exchange: None
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals